Our exploration found that the combined mechanism of these two drugs in AML cells is different, metformin reduced the expression of Mcl-1 in both KG-1 and THP-1 cells not by promoting protein degradation but by inhibiting protein synthesis. The gene discussed is MCL1; the disease is acute myeloid leukemia.